Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients

This study is testing whether oral immunonutrition supplements — special nutritional formulas that support the immune system — can reduce the toxic side effects of chemoradiation therapy in patients with pancreatic cancer. **You may be eligible if...** - You have a confirmed diagnosis of pancreatic ductal cancer - You are receiving chemoradiation therapy — either before surgery (neoadjuvant) or as your main treatment if surgery is not possible - You have some signs of nutritional risk (NRS2002 score ≥3) - You are 18 years of age or older and in reasonably good health (ECOG 0–1) **You may NOT be eligible if...** - You are not receiving chemoradiation - Your nutritional status is adequate (low NRS2002 score) - You are in poor general health or have very short life expectancy Talk to your doctor to see if this trial is right for you.